University of Nebraska Medical Center

Daniel Monaghan, PhD

  • PhD in Biological Sciences, University of California, Irvine, 1985
Research Interests
  • Development of subtype-selective glutamate receptor antagonists to determine the roles of individual receptors in brain function and brain disorders
  • Determine the intracellular signaling pathways by which NMDA receptors regulate neuronal cell function
  • Evaluation of glutamate receptor regulation of neuronal oscillations using electroencephalography

  • American Soc. Neurochemistry
  • American Soc. Pharmacology and Experimental Therapeutics
  • International Soc. Neurochemistry
  • Society for Neuroscience
  • NMDA receptor blockers for the prevention of atherosclerosis.
  • PPDA, a novel NMDA receptor antagonist of unique subtype selectivity.(joint patent between Dr. David Jane, Univ. Bristol and Dan Monaghan)
  • N-Methyl-D-aspartate receptor blockers for the prevention of congenital cardiovascular malformations.